Bisphosphonates for Osteoporosis in Patients with Renal Insufficiency: Pharmacists' Practices and Beliefs.

about

Bisphosphonates for Osteoporosis in Patients with Renal Insufficiency: Pharmacists' Practices and Beliefs.

Item

http://www.wikidata.org/entity/Q36649495

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@ast

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@en

type

Item

label

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@ast

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@en

prefLabel

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@ast

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@en

P1476

Bisphosphonates for Osteoporos ...... acists' Practices and Beliefs.

@en

P2093

Catherine Lyder

http://www.w3.org/2001/XMLSchema#string

Cheryl A Sadowski

http://www.w3.org/2001/XMLSchema#string

Nesé Yuksel

http://www.w3.org/2001/XMLSchema#string

P2860

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Excess mortality following hip fracture: a systematic epidemiological review.

Use of oral bisphosphonates by older adults with fractures and impaired renal function

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials

An opportunity for medication risk reduction, healthcare provider collaboration, and improved patient care: a retrospective analysis of osteoporosis management.

Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.

A single-dose study of denosumab in patients with various degrees of renal impairment.

Public health impact of osteoporosis.

P304

14-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4212/CJHP.V69I1.1518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26985084

http://www.w3.org/2001/XMLSchema#string

P932

4777575

http://www.w3.org/2001/XMLSchema#string